TAKEDA PHARMACEUTICALS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL SENIOR DIRECTOR - REGULATORY AFFAIRS

Takeda Pharmaceuticals – among the top pharmaceutical companies in the world and one of the fastest growing with a U.S. Hub in Massachusetts - has hired Dr. Alu Chatterjee as the new Senior Director of Regulatory Affairs. Dr. Chatterjee has joined from Intarcia Therapeutics, Inc. where he held roles of increasing responsbilities. Prior to Intarcia, Dr. Chatterjee served as Director at Pfizer. He obtained a Ph.D. in Molecular Biology from the University of Windsor. 

This search was successfully led by Christopher Tillman. 

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.